StockData
ResMed Inc logo

ResMed Inc

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3012% below fair value
$235.63−1.25 (-0.53%)

Close on Nov 20, 2026Market cap $33.14BP/E 21.5Yield 1.02%

ResMed Net Cash Provided by Investing Activities

Net Cash Provided by (Used in) Investing Activities ($M) ($M)

Periods

ResMed Net Cash Provided by Investing Activities: $392M in Q1 FY27, down 845.4% from a year earlier. That is the highest of the 69 quarters on record here.

Latest, Q1 FY27
392
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
-845.4%
-52.6 in Q1 FY26
History
69 quarters
Since Q1 FY10
Sources
64
Documents cited below

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet Cash Provided by (Used in) Investing Activities ($M) ($M)Year on yearSource
Q1 FY27CQ3 2026Sep 30, 2026392-845.4%–
Q4 FY26CQ2 2026Jun 30, 2026-384+187.0%ResMed SEC Filing (0000943819-26-000047) ↗
Q3 FY26CQ1 2026Mar 31, 2026-58+82.4%ResMed SEC Filing (0000943819-26-000025) ↗
Q2 FY26CQ4 2025Dec 31, 2025-50.9+38.7%ResMed SEC Filing (0000943819-26-000007) ↗
Q1 FY26CQ3 2025Sep 30, 2025-52.6-2,604.8%ResMed SEC Filing (0000943819-25-000090) ↗
Q4 FY25CQ2 2025Jun 30, 2025-134+187.5%ResMed SEC Filing (0000943819-25-000035) ↗
Q3 FY25CQ1 2025Mar 31, 2025-31.8-4.2%ResMed SEC Filing (0000943819-25-000008) ↗
Q2 FY25CQ4 2024Dec 31, 2024-36.7-10.7%ResMed SEC Filing (0000943819-25-000004) ↗
Q1 FY25CQ3 2024Sep 30, 20242.10-101.4%ResMed SEC Filing (0000943819-24-000027) ↗
Q4 FY24CQ2 2024Jun 30, 2024-46.50.0%ResMed SEC Filing (0000943819-24-000013) ↗
Q3 FY24CQ1 2024Mar 31, 2024-33.2+18.1%ResMed SEC Filing (0000943819-24-000008) ↗
Q2 FY24CQ4 2023Dec 31, 2023-41.1-96.0%ResMed SEC Filing (0000943819-24-000003) ↗
Q1 FY24CQ3 2023Sep 30, 2023-149+153.4%ResMed SEC Filing (0000943819-23-000029) ↗
Q4 FY23CQ2 2023Jun 30, 2023-46.5-15.8%ResMed SEC Filing (0000943819-23-000011) ↗
Q3 FY23CQ1 2023Mar 31, 2023-28.1-43.2%ResMed SEC Filing (0000943819-23-000008) ↗
Q2 FY23CQ4 2022Dec 31, 2022-1,026+1,132.2%ResMed SEC Filing (0000943819-23-000003) ↗

Cite this data

StockData. (2026). ResMed Net Cash Provided by Investing Activities ($M), quarterly Q1 FY10–Q1 FY27 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/db-cf-icf

See every metric in the ResMed KPI table. Data updated Nov 8, 2026.

See a number that looks wrong?